United States · FDA National Drug Code directory
EMROSI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69489-131_335d912c-9d84-1e78-e063-6294a90aa2f9
- Product NDC
- 69489-131
- Form
- CAPSULE
- Composition / generic term
- Minocycline Hydrochloride Extended-Release
- Labeler
- Journey Medical Corporation
- Marketing category
- NDA
- Marketing start / end (source format)
- 20250301
- Source listing expiry
- 20261231
Source-listed ingredients
- MINOCYCLINE HYDROCHLORIDE — 40 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 7 CAPSULE in 1 BOTTLE (69489-131-07) · 69489-131-07
- 30 CAPSULE in 1 BOTTLE (69489-131-30) · 69489-131-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →